Management
Kevin Harter
CEO & CHAIR
Mr. Harter is a healthcare industry veteran with 40+ years of experience that includes operational leadership, business development, and corporate governance.
SCOTT WILLETT
CTO
Dr. Willett has 35+ years’ experience in the biopharmaceutical industry developing and manufacturing recombinant protein human therapeutics.
Jeremy middleton
CBO
Mr. Middleton is an accomplished biopharmaceutical executive with over 35 years of experience and has held senior leadership roles in corporate development, strategic planning and operations at both large and entrepreneurial companies.
Scientific Founders
Dr. Zissis Chroneos is a Professor in the Department of Pediatrics, Microbiology and Immunology, Director of the Pulmonary Immunology and Physiology Laboratory and Core Facility, and Director of Basic Science Research in the Division of Neonatal-Perinatal Medicine in the Department of Pediatrics, Penn State College of Medicine. His long-standing work is on understanding how surfactant proteins and related molecules of the host defense collagen superfamily of proteins modulate inflammation and immunological homeostasis. He is known for the discovery of the surfactant protein A receptor SP-R210 in macrophages in 1996.
Dr. Neil Christensen is a Professor of Pathology, and Microbiology, and Immunology; Associate Chief of Experimental Pathology; and Medical Director, Jake Gittlen Cancer Research Foundation, Penn State College of Medicine. The focus of his research stems from training in the field of immunology with emphasis on animal models of papillomavirus infections and a desire to understand how the immune system combats persistent infections and cancers. A major component of his research involves the construction of a large and diverse set of monoclonal antibodies to various viral and host proteins with strength in probes that recognize HPV capsids and that have virus-neutralizing activities.
ANDY AGRAWAL, JD
DIRECTOR
Timothy j. pelura, phd
Director
michele washko, mba